Clinical trials
4 active studies led by Dyne Therapeutics, of 4 in all
Source: ClinicalTrials.gov, Studies with Dyne Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 2Markets in public records
- 0Regions & countries
- 4Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Dyne Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Dyne Therapeutics
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Stock listing
- NASDAQ: DYN
- Type
- Medicines
Source: SEC EDGAR, Company filings, CIK 1818794. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
2 510(k) clearances and PMA approvals since 2015
- Dyne Port K252933 · 12 Jun 2026
- Urus System (Dmg-Su100/Urus); Urus System (Dmg-Su100R/Urus); Urus System (Vp-10… K240203 · 5 Sep 2024
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
SEC filings
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1818794.
Trials over time
Studies Dyne Therapeutics leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Dyne Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Dyne Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Dyne Therapeutics is in.
From our blog
Stories on the topics Dyne Therapeutics works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Eye Health Supplements: Screens, Ageing and Vision
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Herbal Supplements: Quality, Safety and Trust
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read